Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Johnson

Orthopaedic Surgery Birmingham, AL Medical Doctor

NPI 1275748428 CMS profile 1055270

1201 11Th Ave S, Birmingham, AL 35205

Open in the dashboard

General payments

$74,044

149 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$5,400 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Michael Johnson of Birmingham, AL is reported in the CMS Open Payments database as having received $74,044 across 149 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $5,400 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 91st percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,140 12
2024 General $10,709 12
2023 General $44,305 61
2022 General $15,145 31
2021 General $351 11
2020 General $264 9
2019 General $2,131 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Johnson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Michael Johnson were reported at $1,140. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Michael Johnson Orthopaedic Surgery median Middle half National median
2019 $2,131 $644 $140–$2,844 $163
2020 $264 $312 $75–$1,860 $114
2021 $351 $520 $117–$2,495 $132
2022 $15,145 $598 $128–$2,731 $149
2023 $44,305 $461 $128–$2,264 $160
2024 $10,709 $497 $134–$2,475 $164
2025 $1,140 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $53,892 103 payments
  2. Tyber Medical, LLC $15,715 3 payments
  3. Stryker Corporation $1,592 17 payments
  4. In2Bones USA, LLC $1,570 4 payments
  5. Smith+Nephew, Inc. $365 5 payments
  6. DePuy Synthes Sales Inc. $169 6 payments
  7. Orthofix Medical, Inc. $151 1 payment
  8. TriMed, Inc. $122 1 payment
  9. ERMI Inc. $120 1 payment
  10. Wright Medical Technology, Inc. $102 1 payment
  11. Other $245 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $56,798 28 payments
  2. Travel and Lodging $8,619 31 payments
  3. Food and Beverage $5,214 86 payments
  4. Education $3,372 3 payments
  5. Entertainment $40 1 payment
Products named General payments · program years 2019–2025
  1. InCore Lapidus $26,305 35 payments
  2. Tyber Medical Anatomical Plating System $15,715 3 payments
  3. ALPS Plating System $15,715 3 payments
  4. Stratum Foot Plating System $9,566 6 payments
  5. Trabecular Metal $3,666 11 payments
  6. Tapestry $2,500 2 payments
  7. TriWay TTC Nail $1,570 4 payments
  8. INFINITY $467 4 payments
  9. AUGMENT INJECTABLE $324 4 payments
  10. INBONE $319 2 payments
  11. Other $2,368 53 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Orthopedic Surgery: 203

Drug cost

$42

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 12 $42

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 86 billing codes

Paid by Medicare

$62,999

Medicare's payments for the services billed

Medicare patients

116

Average age 67

Services billed

365

72 women, 44 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 34%
Diabetes 32%
Ischemic heart disease 27%
Chronic kidney disease 21%
COPD 18%
Osteoporosis 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

149 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record